Urinary Incontinence
Conditions
Interventions
This is a two-arm randomized controlled clinical trial with single masking, totaling 100 participants randomly allocated by a computerized system, with 50 women in the intervention group and 50 women
Sponsors
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Women; aged between 18 and 65 years; absence of menstruation for more than 12 months; breast cancer under treatment or post-treatment; complaints of genitourinary syndrome of menopause, including vaginal, sexual, and urinary symptoms; complaints of urinary incontinence; availability to attend therapy sessions on the scheduled date and location for the treatment
Exclusion criteria
Exclusion criteria: Use of vaginal moisturizers in the last 30 days; active urinary tract or vaginal infection; presence of pelvic organ prolapse classified as stage III and IV; cognitive or psychiatric impairment that prevents understanding of the treatment instruments used
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement i in the Vaginal Health Index score at days 30, 90, and 180 after the intervention, with improvements in the parameters of elasticity, volume, pH, epithelial integrity, and vaginal moisture ;An improvement in vaginal, sexual, and urinary symptoms is expected in the group treated with the intervention;An improvement in muscle strength is expected in the group treated with the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary stages are expected | — |
Countries
BR
Contacts
Public ContactCassia Juliato
Universidade Estadual de Campinas
Outcome results
None listed